A comparison of mivacurium infusion requirements between young and elderly adult patients

European Journal of Anaesthesiology

Volumn 13, Issue 1, 1996, Pages 43-48

  Dahaba, A A ^a   Rehak, P H ^a   List, W F ^a,b  

^a UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Intubation, tracheal, conditions; Monitoring, neuromuscular function, electromyography; Neuromuscular relaxants, mivacurium, infusion, age

Indexed keywords

FENTANYL; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; PROPOFOL;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTIVE SURGERY; ELECTROMYOGRAM; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; ULNAR NERVE;

EID: 0030063320     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-199601000-00009     Document Type: Article

References (14)

1. Savarese JJ, Wastila WB, El Sayad HA. Some aspects of the basic and clinical pharmacology of mivacurium (BW B109OU) and doxacurium (BW A938U). A preliminary report. International Congress Symposium Series 1988; 131: 55-60.
2. Mirakhur RK. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use. Drugs 1992; 44: 182-199.
3. Ali HH, Savarese JJ, Embree PB et al. Clinical pharmacology of mivacurium chloride (BW B109 OU) infusion, comparison with vecuronium and atracurium. Br J Anaesth 1988; 61: 541-546.
4. Savarese JJ, Ali HH, Basta SJ et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B109 OU). A short-acting non depolarizing ester neuromuscular blocking drug. Anesthesiol 1988; 68: 723-732.
5. Basta SJ. Clinical pharmacology of mivacurium chloride. A Review. Journal of Clinical Anesthesia 1992; 4: 153-163.
6. Goldhill DR, Whitehead JP, Emmott RS, Griffith AP, Bracey BJ, Flynn PJ. Neuromuscular and clinical effects of Mivacurium chloride in healthy adult patients during nitrous oxide-enflurane anesthesia. Br J Anaesth 1992; 67: 289-295.
7. Basta SJ, Dresner DL, Shaft LP, Lai AA, Welch R. Neuromuscular effects of pharmacokinetics of mivacurium in older patients under isoflurane anesthesia. Anesth Analg 1989; 68: S18.
8. Maddineni VR, Mirakhur RK, McCoy EP, Sharpe TDE. Neuromuscular and haemodynamic effects of mivacurium in elderly and young adult patients. Br J Anaesth 1994; 73: 608-612.
9. Young HSA, Clarke RSJ, Dundee JW. Intubating conditions with AH 8165 and suxamethonium. Anaesthesia 1975; 30: 30-33.
10. Maddineni VR, Mirakhur RK, McCoy EP, Fee JPH, Clark RSJ. Neuromuscular effects and intubating conditions following mivacurium: A comparison with suxamethonium. Anaesthesia 1993; 48: 940-945.
11. Maddineni VR, Mirakhur RK, McCoy EP. Plasma cholinesterase activity in elderly and young adults. Br J Anaesth 1994; 72: 497.
12. Mirakhur RK, Lavery TD, Briggs LP, Clarke RSJ. Effects of neostigmine and pyridostigmine on serum cholinesterase activity. Can Anaesth Soc J 1982; 29: 55-58.
13. From RP, Pearson KS, Choi WW, Abou-Donia MM, Sokoll MD. Neuromuscular and cardiovascular effects of mivacurium chloride (BW B109 OU) during nitrous oxide-fentanyl-thiopentone and nitrous oxide-halothane an aesthesia. Br J Anaesth 1990; 64: 193-198.
14. Savarese JJ, Ali HH, Basta SJ et al. The cardiovascular effects of mivacurium chloride (BW B109 OU) in patients receiving nitrous oxide-opiate-barbiturate anesthesia. Anesthesiol 1989; 70: 386-394.